HUP9877967A2 - Use of 3,4-diphenyl chromans for manufacture of a pharmaceutical composition for treatment or prophylaxis of gynaecological disorders - Google Patents

Use of 3,4-diphenyl chromans for manufacture of a pharmaceutical composition for treatment or prophylaxis of gynaecological disorders

Info

Publication number
HUP9877967A2
HUP9877967A2 HU9702244A HU9702244A HUP9877967A2 HU P9877967 A2 HUP9877967 A2 HU P9877967A2 HU 9702244 A HU9702244 A HU 9702244A HU 9702244 A HU9702244 A HU 9702244A HU P9877967 A2 HUP9877967 A2 HU P9877967A2
Authority
HU
Hungary
Prior art keywords
prophylaxis
manufacture
treatment
pharmaceutical composition
gynaecological disorders
Prior art date
Application number
HU9702244A
Other languages
Hungarian (hu)
Other versions
HUP9702244A3 (en
Inventor
Martin William Edwards
Birgitte Hjort Guldhammer
Ved Prakash Kamboj
Niels Korsgaard
Virender Mohan Labroo
James Robertson Piggott
Suprabhat Ray
Michael Shalmi
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of HUP9877967A2 publication Critical patent/HUP9877967A2/en
Publication of HUP9702244A3 publication Critical patent/HUP9702244A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
HU9702244A 1995-01-13 1995-01-10 Use of 3,4-diphenyl chromans for manufacture of a pharmaceutical composition for treatment or prophylaxis of gynaecological disorders HUP9702244A3 (en)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
DK4695 1995-01-13
DK4895 1995-01-13
DK4595 1995-01-13
DK4795 1995-01-13
DK4495 1995-01-13
DK76895 1995-06-30
DK77095 1995-06-30
DK77295 1995-06-30
DK76995 1995-06-30
DK77195 1995-06-30

Publications (2)

Publication Number Publication Date
HUP9877967A2 true HUP9877967A2 (en) 1998-12-28
HUP9702244A3 HUP9702244A3 (en) 1999-12-28

Family

ID=27579214

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9702244A HUP9702244A3 (en) 1995-01-13 1995-01-10 Use of 3,4-diphenyl chromans for manufacture of a pharmaceutical composition for treatment or prophylaxis of gynaecological disorders

Country Status (11)

Country Link
EP (1) EP0804190A1 (en)
JP (1) JPH10511962A (en)
CN (1) CN1168096A (en)
AU (1) AU693628B2 (en)
CA (1) CA2208861A1 (en)
CZ (1) CZ212297A3 (en)
HU (1) HUP9702244A3 (en)
IL (1) IL116746A0 (en)
MX (1) MX9705219A (en)
NO (1) NO973243D0 (en)
WO (1) WO1996021444A1 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985306A (en) * 1996-10-28 1999-11-16 Novo Nordisk A/S (+)-enantiomers of cis-3,4-chroman derivatives useful in prevention or treatment of estrogen diseases or syndromes
WO1998018776A1 (en) * 1996-10-28 1998-05-07 Novo Nordisk A/S Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
AU4772197A (en) * 1996-10-28 1998-05-22 Novo Nordisk A/S Novel (cis)-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
ZA979644B (en) * 1996-10-28 1998-04-28 Novo Nordisk As Heterocyclic compounds, compositions and uses.
US5994390A (en) * 1996-10-28 1999-11-30 Novo Nordisk Trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
US6316494B1 (en) 1996-10-28 2001-11-13 Novo Nordisk A/S cis3, 4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
WO1998018778A1 (en) * 1996-10-28 1998-05-07 Novo Nordisk A/S Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
ZA979646B (en) * 1996-10-28 1998-04-28 Novo Nordisk As Heterocyclic compounds, compositions and uses.
US5958967A (en) * 1996-10-28 1999-09-28 Novo Nordisk A/S Cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
US6043269A (en) * 1996-10-28 2000-03-28 Novo Nordisk A/S cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
ZA979643B (en) * 1996-10-28 1998-04-28 Novo Nordisk As Heterocyclic compounds, compositions and uses.
DK0937062T3 (en) * 1996-10-28 2003-04-07 Novo Nordisk As New cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen-related diseases or syndromes
US5919817A (en) * 1996-10-28 1999-07-06 Novo Nordisk A/S Cis-3, 4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
AU4700097A (en) * 1996-10-28 1998-05-22 Novo Nordisk A/S Novel (cis)-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
IL129625A0 (en) * 1996-10-28 2000-02-29 Novo Nordisk As Novel (-)-enantionmers of CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
JP4896335B2 (en) * 2000-03-01 2012-03-14 ナームローゼ・フエンノートチヤツプ・オルガノン Chroman derivatives as estrogen compounds
AU2005287865B2 (en) 2004-09-21 2012-02-16 Marshall Edwards, Inc. Substituted chroman derivatives, medicaments and use in therapy
US8080675B2 (en) 2004-09-21 2011-12-20 Marshall Edwards, Inc. Chroman derivatives, medicaments and use in therapy
EP2635121B1 (en) 2010-11-01 2020-01-08 MEI Pharma, Inc. Isoflavonoid compounds and methods for the treatment of cancer
PT2953938T (en) 2014-02-07 2017-10-09 Novogen ltd Functionalised benzopyran compounds and use thereof
PL3253208T3 (en) 2015-02-02 2021-11-08 Mei Pharma, Inc. Combination therapies for use in the treatment of breast cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5407955A (en) * 1994-02-18 1995-04-18 Eli Lilly And Company Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease

Also Published As

Publication number Publication date
AU693628B2 (en) 1998-07-02
WO1996021444A1 (en) 1996-07-18
HUP9702244A3 (en) 1999-12-28
NO973243L (en) 1997-07-11
CA2208861A1 (en) 1996-07-18
CZ212297A3 (en) 1997-11-12
JPH10511962A (en) 1998-11-17
CN1168096A (en) 1997-12-17
MX9705219A (en) 1997-10-31
EP0804190A1 (en) 1997-11-05
IL116746A0 (en) 1996-05-14
AU4329396A (en) 1996-07-31
NO973243D0 (en) 1997-07-11

Similar Documents

Publication Publication Date Title
HUP9702244A3 (en) Use of 3,4-diphenyl chromans for manufacture of a pharmaceutical composition for treatment or prophylaxis of gynaecological disorders
IL121170A0 (en) Compositions for the treatment of dermatological disorders
HK1008180A1 (en) Use of vitamin d 2 or vitamin d 4-derivatives for the manufacture of a medicament for the treatment of secondary hyperparathyroidism
AU4060599A (en) Pharmaceutical composition for treating or preventing sleep disorders
HUP9902683A3 (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of menopausal symptoms
AU1367397A (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of atrophy of skin and/or mucous membranes
PL322526A1 (en) Azathiopyrin compositions for intracolic administration
HUP9702246A3 (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of degenerative cerebral disorders
HUP9800334A3 (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of obesity
IL116745A0 (en) Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions
HK1017684A1 (en) Novel substituted 4-(1h-benzimidazol-2-yl)(1,4)diazepanes useful for the treatment of allergic diseases
CA2260863A1 (en) Treatment of psychotic disorders
AU5627796A (en) Medicaments for the treatment or prophylaxis of ischemia-reperfusion injury
AU4329196A (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for vasodilatory treatment or prophylaxis
HUP9800133A3 (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment of prophylaxis of idiopathic or physiologic gynaecomastia
AU686084B3 (en) Pharmaceutical compositions for the treatment of depressive disorders
ZA98682B (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for inhibiting one or more psychiatric disorders
ZA96439B (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment of prophylaxis of cerebral degenerative disorders
ZA96446B (en) Use of 3,4-diphenyl chromans for the manufacture of pharmaceutical composition for the treatment or prophylaxis of obesity
ZA96440B (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for vasodilatory treatment or prophylaxis
ZA97168B (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment of prophylaxis of prostatic carcinoma
ZA97170B (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment of prophylaxis of menopausal symptoms.
ZA96248B (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of idiopathic or physiologic gynaecomastia
AU5768298A (en) Use of benzoylalkyl-1,2,3,6-tetrahydropyridins
IL126276A0 (en) The use of an inhibitor of the na+/H+ exchanger for the production of a medicament for the treatment or prophylaxis of disorders of the central nervous system